openPR Logo
Press release

United States Neurovascular Stents Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities

09-30-2025 02:50 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Neurovascular Stents Market - DataM Intelligence

Neurovascular Stents Market - DataM Intelligence

Neurovascular Stents Market reached US$ 1,251.75 million in 2024 and is projected to reach US$ 3,040.53 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

DataM Intelligence unveils its latest report on the "Neurovascular Stents Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurovascular-stents-market?sg

List of Top Key Player: Stryker, Acandis GmbH, Balt Group, Boston Scientific Corporation, Terumo Corporation and MicroPort Scientific Corporation.

United States Mergers & Acquisitions:

✅ Stryker-Inari Medical Acquisition: Stryker announced the acquisition of Inari Medical for $4.9 billion, enhancing its neurovascular portfolio with Inari's thrombectomy and venous thromboembolism devices. This strategic move aims to expand Stryker's presence in the neurovascular segment, which is projected to be a $1.3 billion annual business.

United States Product Launches

✅ Boston Scientific launched the Neuroform EZTM Stent System in July 2025. This fourth-generation intracranial aneurysm stent system is designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The launch occurred simultaneously in the U.S. and Europe, expanding Boston Scientific's market-leading family of neurovascular stents.

Japan - Product Launches

✅ Boston Scientific - TAXUS Liberte Stent: Boston Scientific launched the TAXUS Liberte drug-eluting stent in Japan, marking it as the only second-generation drug-eluting stent available in the country. This launch expands Boston Scientific's coronary intervention portfolio in Japan.

Forecast Projection:

The Global Neurovascular Stents Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Neurovascular Stents Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neurovascular-stents-market?sg

Key Segmentation:

By Type (Intracranial Stents, Carotid Artery Stents)

By Material (Polymers, Metal, Others)

By Application (Carotid Artery Stenosis, Cerebral Aneurysms, Arteriovenous Malformations and Fistulas, Others)

By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others)

By Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Neurovascular Stents Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurovascular-stents-market?sg

FAQ's

Q1: What is the current size of the Neurovascular Stents Market and its future potential?

A: The Neurovascular Stents Market was valued at US$ 1,251.75 million in 2024 and is projected to surge to US$ 3,040.53 million by 2033

Q2: How fast is the Neurovascular Stents Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 10.4% between 2025 and 2032, signaling strong global growth and investment potential.

Q3: Which regions are dominating the Neurovascular Stents Market and which are fastest-growing?

A: North America is expected to dominate the neurovascular stents market.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Neurovascular Stents Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities here

News-ID: 4204302 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Hips & Knees Reconstructive: Personalized Implants & 3.6% CAGR By 2024-2031 | Leading Companies - Zimmer Biomet, Depuy Synthes, Smith & Nephew plc, Stryker
United States Hips & Knees Reconstructive: Personalized Implants & 3.6% CAGR By …
Market Size and Forecast: The Global Hips & Knees Reconstructive Market reached US$ 17.30 billion in 2023 and is expected to reach US$ 22.93 billion by 2031, growing at a CAGR of 3.6% during the forecast period 2024-2031. The Hips and Knees Reconstructive Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses
Japan Single-Use Bioprocessing Products Market: Thermo Fisher, Sartorius & Cytiva Share - 2024-2031
Japan Single-Use Bioprocessing Products Market: Thermo Fisher, Sartorius & Cytiv …
Market Size and Forecast: Japan Single-Use Bioprocessing Products Market is expected to reach growth at a Significant CAGR during the forecast period 2024-2031 The Japan Single-Use Bioprocessing Products Market Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of
United States Pharmaceutical Packaging Market to Grow at 9.5% CAGR, Driven by Regulatory Compliance, Smart Packaging Adoption, and Biologics Expansion | DataM Intelligence
United States Pharmaceutical Packaging Market to Grow at 9.5% CAGR, Driven by Re …
The global Pharmaceutical Packaging Market is growing at a CAGR of 9.5% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Amcor PLC launched a new series of recyclable cold-chain packaging solutions for biologic drugs, enhancing sustainability in temperature-sensitive shipments. ✅ In October 2025, West Pharmaceutical Services introduced a novel smart vial system with integrated sensors for real-time temperature and tamper monitoring. ✅
United States Optical Imaging Market to Grow at 12.4% CAGR, Reaching USD 4.0 billion by 2031, Led by Canon, Carl Zeiss, and Abbott Laboratories | DataM Intelligence
United States Optical Imaging Market to Grow at 12.4% CAGR, Reaching USD 4.0 bil …
The global Optical Imaging Market reached USD 1.6 billion in 2022 and is projected to reach USD 4.0 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Canon U.S.A. received FDA clearance for its next-generation optical coherence tomography (OCT) system with AI-enhanced diagnostic capabilities for ophthalmology. ✅ In October 2025, Abbott Laboratories

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients